Loading...
Please wait, while we are loading the content...
Similar Documents
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines.
| Content Provider | Europe PMC |
|---|---|
| Author | Wright, Edwina Grulich, Andrew Roy, Katy Boyd, Mark Cornelisse, Vincent Russell, Darren O'Donnell, Darryl Whittaker, Bill Crooks, Levinia Zablotska, Iryna |
| Abstract | AbstractDaily use of coformulated tenofovir and emtricitabine for HIV pre-exposure prophylaxis (PrEP) by populations at high risk of HIV infection is now recommended in guidelines from the United States, Europe and Australia and globally through the 2015 WHO guidelines. These 2017 Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine's (ASHM) PrEP Guidelines are an updated adaptation of the 2014 US Centers for Disease Control's PrEP guidelines and are designed to:•Support the prescription of PrEP using forms of coformulated tenofovir and emtricitabine that have been registered in Australia by the Therapeutic Goods Administration and other bioequivalent generic drugs that are available in Australia through self-importation, private prescription or Australian PrEP clinical trials•Assist clinicians in the evaluation of patients who are seeking PrEP•Assist clinicians in commencing and monitoring patients on PrEP including PrEP dosing schedules, management of side-effects and toxicity, use of PrEP in pregnancy and in chronic hepatitis B infection and how to cease PrEPDaily PrEP with co-formulated tenofovir and emtricitabine, used continuously or for shorter periods of time, is recommended in these guidelines as a key HIV-prevention option for men who have sex with men (MSM), transgender men and women, heterosexual men and women, and people who inject drugs (PWID) at substantial risk of HIV acquisition. |
| Related Links | https://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC5518248&blobtype=pdf |
| ISSN | 20556640 |
| Journal | Journal of Virus Eradication [J Virus Erad] |
| Volume Number | 3 |
| PubMed Central reference number | PMC5518248 |
| Issue Number | 3 |
| PubMed reference number | 28758027 |
| e-ISSN | 20556659 |
| Language | English |
| Publisher | Mediscript Ltd |
| Publisher Date | 2017-07-01 |
| Access Restriction | Open |
| Rights License | This is an open access article published under the terms of a Creative Commons License. © 2017 The Authors. Journal of Virus Eradication published by Mediscript Ltd |
| Subject Keyword | pre-exposure prophylaxis PrEP TD*/FTC |
| Content Type | Text |
| Resource Type | Article |
| Subject | Infectious Diseases Virology Public Health, Environmental and Occupational Health Immunology Epidemiology |
